• Idoxuridine Workflows for Viral DNA Assays

  2026-08-26

  Idoxuridine enables controlled studies of viral DNA synthesis inhibition while its DMSO solubility supports concentrated research stocks. This practical guide connects concentration design, orthogonal antiviral readouts, solvent controls, and troubleshooting for reproducible cell-based assays.

• 4-MUG for Lysosomal Enzyme Activity Assays

  2026-08-26

  4-MUG converts β-glucosidase and β-glucocerebrosidase hydrolysis into a sensitive fluorescent readout for cell, lysate, and screening workflows. This practical guide connects assay design with the latest GBA1 mRNA research while emphasizing controls, kinetic validation, and troubleshooting.

• Roscovitine (Seliciclib, CYC202) in Cell Assays

  2026-08-25

  This scenario-based guide explains how to use Roscovitine (Seliciclib, CYC202) in cell-cycle, viability, proliferation, and cytotoxicity workflows while separating cytostasis from cell death. It covers solvent controls, concentration design, data interpretation, and practical selection of SKU A1723.

• Pcbp1, Mitochondrial Integrity, and B Cell Immunity

  2026-08-25

  The reference study identifies the RNA-binding protein Pcbp1 as a posttranscriptional regulator of mitochondrial integrity, protein translation, and antibody responses in B cells. Its connection between Pcbp1, Fdxr expression, complex I function, and germinal center development provides a mechanistic framework for interpreting protein synthesis measurement in cells during humoral immune responses.

• BCA Protein Quantification Kit: Practical Guide

  2026-08-24

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit, SKU K4102, provides sensitive total-protein measurement for dilute samples and many detergent-containing biochemical samples. It is intended for research workflows such as cell-lysate normalization, not for diagnostic, clinical, or medical testing.

• Metronidazole as a Translational Mechanism Tool

  2026-08-24

  Metronidazole offers translational researchers a dual-use platform: a nitroimidazole antibiotic for anaerobic bacteria targeting and protozoa treatment research, and a mechanistic OAT3 inhibitor for studying transporter-mediated drug-drug interaction modulation. This article connects transporter biology, microbial assay design, evidence-based workflow development, and strategic interpretation beyond the scope of a conventional product page.

• Idoxuridine: From Viral Mechanism to Translation

  2026-08-23

  Idoxuridine, also known as 5-iodo-2'-deoxyuridine, remains a useful mechanistic probe for viral DNA synthesis. This thought-leadership perspective connects its nucleoside biology with translational assay design, product-handling strategy, and lessons from human-neuron pharmacology without overstating evidence across domains.

• Cy3 TSA Fluorescence System Kit for IHC and ISH

  2026-08-22

  The Cy3 TSA Fluorescence System Kit converts HRP activity into localized, high-density Cy3 deposition for sensitive IHC, ICC, and ISH. This workflow-focused guide explains how to apply a TSA fluorescence kit to low-abundance targets, spatial immune studies, and difficult tissue samples while controlling background and false-positive signal.

• Camostat Mesilate: Assay Logic Across Protease and PPI Biolo

  2026-08-22

  Camostat Mesilate is a trypsin-like protease inhibitor whose value depends on separating ENaC-linked, plasmin–TGF-β, and fibrosis readouts from viral protein–protein interaction assays. This guide translates structure-guided proteomimetic research into practical decisions for controls, endpoints, and mechanism-focused workflows.

• Dietary Arachidonic Acid and Humoral Immunity

  2026-08-21

  The reference study shows that dietary arachidonic acid can accelerate rabies vaccine-induced neutralizing antibody responses and improve protection in mice, with a related effect observed in human volunteers. Its central mechanistic contribution is linking lymph-node arachidonic acid metabolism to prostaglandin I2–cAMP–PKA signaling, CD86 expression, and activation-induced cytidine deaminase in B cells.

• Radioiodinated Balsalazide for UC Imaging

  2026-08-20

  The reference study developed and evaluated radioiodinated balsalazide as a colon-associated tracer for imaging ulcerative colitis in mice. Its combination of optimized labeling, 24-hour stability testing, and comparative biodistribution provides a practical framework for inflammation research while leaving important questions about receptor specificity, disease-model generalizability, and clinical translation unresolved.

• TRIM66 and Monogenic Olfactory Receptor Expression

  2026-08-20

  This Nature Communications study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence surplus olfactory receptor genes. Genetic loss of Trim66 preserves low-level expression of multiple receptors, reduces overall receptor expression, and disrupts olfactory neural processing and innate behaviors, linking enhancer repression to sensory function.

• Cycloastragenol in Glucocorticoid-Induced Osteonecrosis

  2026-08-19

  This in vivo study shows that cycloastragenol limits femoral-head damage in a methylprednisolone-induced rat model of glucocorticoid-induced osteonecrosis. By combining micro-CT, angiography, histology, qPCR, and Western blotting, the work links structural preservation with reduced osteoclast activity and a lower RANKL-to-OPG signaling balance.

• Leucomycin (Kitasamycin) Assay Workflows

  2026-08-19

  Leucomycin, or kitasamycin, offers a practical macrolide model for bacterial growth inhibition assays, translational inhibition studies, and 23S rRNA resistance mapping. This guide converts evidence from a swine dysentery study into bench-ready workflows, comparative assay strategies, and troubleshooting decisions.

• Fangchinoline, TFEB, and Anti-H1N1 Lysosomal Defense

  2026-08-18

  The reference study identifies fangchinoline as a host-directed anti-influenza compound that restores TFEB-associated lysosomal biogenesis while disrupting endolysosomal trafficking required for H1N1 entry. Its combined use of Connectivity Map screening, transcriptomic analysis, lysosomal assays, time-resolved infection experiments, and in vivo validation provides a framework for studying lysosome-targeted antiviral mechanisms.

8525 records 1/569 page Next 12345 下5页 Last page